Brighter AB further extends its network with another prominent clinician and scientist.

                                              Press release Stockholm 2015-01-26

Brighter further extends its network with another prominent clinician and
scientist.

In  January cooperation  will be  initiated with  Doc. Michael  Alvarsson, chief
physician  at Karolinska University  Hospital in Solna,  who will function as an
advisor for Brighter within the medical field.

Michael  is active  at the  Clinic of  Endocrinology, Metabolism and Diabetes as
well  as conducting  clinical diabetes  research at  the Department of Molecular
medicine and Surgery (MMK) at Karolinska institute. The cooperation entails that
Brighter   further  strengthens  its  competence  regarding  practical  diabetes
treatment and research within endocrinology.

-  The cooperation is a part of our continuous effort to ensure that Brighter is
at  the  forefront  regarding  development  in research. Hence Brighter actively
broadens  and deepens its internal knowledge in prioritized areas of focus. This
also  strengthens  Brighter  in  ongoing  negotiations  with  a  number of major
international  companies  within  pharmaceutical,  e-health  and  communications
sectors, says Truls Sjöstedt, Brighter's CEO and founder.

About Brighter AB
Brighter  creates innovations  which make  life easier  for people living with a
disease.  The  first  idea  is  about  making  insulin treatment easier and more
effective.  Brighter  has,  through  its  patented  device,  developed  a unique
solution which combines diagnostics, medication and journaling in one device. It
gives  millions  of  diabetics  across  the  globe  the possibility for improved
quality  of life.  Generated data  can be  shared and  followed up  and thus the
device  functions as  a link  between the  patient's everyday  treatment and the
healthcare's treatment plan. The increase in quality and cost efficiency that is
made  possible  will  benefit  patients,  caregivers, payers and authorities. We
believe  that  simplicity  and  access  drive  behavioral  change  and  that the
responsibility  for  health  increasingly  is  shifted  towards  the individual.
Therefore  we want to understand people and  their situation in life in order to
develop  easy, smart and  reliable solutions which  simplify their everyday life
and increase the quality of treatment.


The Company's shares are listed on NASDAQOMX First North/BRIG.

Visit our website and subscribe to press releases: www.brighter.se
Follow us on:
www.introduce.se

Certified Adviser
Brighter's  Certified Adviser on Nasdaq OMX First North is Remium Nordic AB, Per
Grundström +46 (0)8 - 454 32 29, CorporateFinance@remium.com, www.remium.com.

For further information, please contact:
 Henrik Norström, COO               Truls Sjöstedt, VD
 Telephone: +46 733 40 30 45        Telephone : +46 709 73 46 00
 Email: henrik.norstrom@brighter.se Email: truls.sjostedt@brighter.se




[HUG#1889236]